Companies · Other Health Care

RT Oncology Services Corp

SAN DIEGO · Other Health Care

Diligence memoA one-page analyst read on RT Oncology Services Corp — recommendation, valuation, rhythm, risks.
$56.5M
Total raised · real
4
Rounds
0.0×
Latest step-up
Top 8%
Sector rank · raised
Series B
Latest stage · inferred · Fri Jul 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

RT Oncology Services Corp looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.01× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era.
Dormant
  • Last raise 11.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

RT Oncology Services Corp is one of 5376 Other Health Care companies tracked from SAN DIEGO. By capital raised it ranks among the largest (ahead of 93% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2011-07-01 Raised $23M (real) Modeled valuation $505M (est)$23M$505MSeries B2011Series B · 2011-07-01 Raised $22M (real) Modeled valuation $498M (est)$22M$498MSeries B2011Series A · 2011-07-01 Raised $11M (real) Modeled valuation $223M (est)$11M$223MSeries A2011Series B · 2015-07-17 Raised $225K (real) Modeled valuation $5.0M (est)$225K$5.0MSeries B2015+$22M+$11M+$225KCumulative $57M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$22.8M · 2011
Series B extension$22.5M · 2011
Bridge · Series B-stage$11.1M · 2011smaller follow-on
Series B extension$225K · 2015

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$5.0M
Base estimate est.
$529K
Conservative case
$19.2M
Upside case
$1.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $504.8M · 2011-07-012011Series B · modeled $497.5M · 2011-07-01Series A · modeled $223.5M · 2011-07-01Series B · modeled $5.0M · 2015-07-172015
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
11.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
16 mo
Avg between rounds
$14.0M/yr
Capital velocity
15.0 yr
On record since
2011
First round
4
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 23× above median
This company$56.5M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.0× of median
This company$225K
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$5.0M
Sector median$22.1M

Raised more than 93% of sector peers (real $). Modeled value above 21% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #85 of 85.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Drynachan, Llc · Series B Raised $40.0M · modeled $886.2M (est)Vistria SHC Holdings, LLC · Series B Raised $39.7M · modeled $879.5M (est)Ebh Holding Company, Inc. · Series B Raised $70.9M · modeled $871.1M (est)Orthopediatrics Corp · Series B Raised $57.5M · modeled $864.0M (est)Assurerx Health, Inc · Series B Raised $51.5M · modeled $828.4M (est)IMRIS Inc. · Series B Raised $36.8M · modeled $816.0M (est)Remedy Partners, Inc. · Series B Raised $56.4M · modeled $795.3M (est)Hansen Medical Inc · Series B Raised $126.0M · modeled $775.4M (est)BCOM Investment Partners, LLC · Series B Raised $34.5M · modeled $764.3M (est)Michigan Critical Care Consultants, Inc. · Series B Raised $34.0M · modeled $753.2M (est)HY Holdings, Inc. · Series B Raised $33.0M · modeled $731.1M (est)Medical Solutions L.L.C. · Series B Raised $32.5M · modeled $720.0M (est)RT Oncology Services Corp (this company) Raised $56.5M · modeled $5.0M (est)RT Oncology Services Corp
CompanyStageRaised · realValue · estvs peer med.
Drynachan, LlcSeries B$40.0M$886.2M2.00×
Vistria SHC Holdings, LLCSeries B$39.7M$879.5M1.99×
Ebh Holding Company, Inc.Series B$70.9M$871.1M1.97×
Orthopediatrics CorpSeries B$57.5M$864.0M1.95×
Assurerx Health, IncSeries B$51.5M$828.4M1.87×
IMRIS Inc.Series B$36.8M$816.0M1.84×
Remedy Partners, Inc.Series B$56.4M$795.3M1.79×
Hansen Medical IncSeries B$126.0M$775.4M1.75×
BCOM Investment Partners, LLCSeries B$34.5M$764.3M1.72×
Michigan Critical Care Consultants, Inc.Series B$34.0M$753.2M1.70×
HY Holdings, Inc.Series B$33.0M$731.1M1.65×
Medical Solutions L.L.C.Series B$32.5M$720.0M1.62×
RT Oncology Services Corp this companySeries B$56.5M$5.0M0.01×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$22.8M2011-07-01$126.6M$504.8M90%
Series B$22.5M2011-07-01$124.8M$497.5M90%
Series A$11.1M2011-07-01$50.3M$223.5M90%
Series B$225K2015-07-17$1.3M$5.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$22.8M2011-07-01
    • First recorded raise — entered as Series B.
  2. Series B$22.5M2011-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  3. Series A$11.1M2011-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.0× smaller than the prior — bridge or down round.
  4. Series B$225K2015-07-17
    • Raised again after 49 mo — slower than the ~14 mo sector norm.
    • Round 49.2× smaller than the prior — bridge or down round.
Intelligence
2016 ~Q4
Modeled next raise · ~16mo cadence
$225K
Modeled next size est.range $225K$360K
0.0×
Last step-up
$14.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Michael Martin10 other2011-07
Mark Pacala4 other2015-07
Steven B. Gruber2 other2015-07
Alan Hoops1 other2015-07
Charles B. Patton1 other2011-07
Gregory Lucier1 other2015-07
Harry Eichelberger1 other2011-07
Mark L. Pacala1 other2011-07
SRIRAM IYER1 other2015-07
Craig Mundie2015-07
John Creelman2011-07
William N. Harwin, M.D.2011-07
Registry & provenance

RT Oncology Services Corp is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1517791
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
High Plains Physicians, LLCOther Health CareSeries B$16.8M$371.7Mnetwork1 shared operator · same sector · same stage
Ascension Health Care Network, Inc.Hospitals and PhysiciansPre-Seed$500K$14.3Mnetwork3 shared operators
Vera Whole Health, Inc.HealthtechSeries B$46.4M$247.8Mnetwork1 shared operator · same stage
InHomeTherapy, Inc.Other Health CareSeries A$20.4M$25.5Mnetwork1 shared operator · same sector
Positive Development, Inc.OtherSeries B$72.2M$119.7Mnetwork1 shared operator · same stage
Pascal Metrics Inc.Other Health CareSeries A$10.9M$20.8Mnetwork1 shared operator · same sector
Vascular Therapies IncBiotechnologySeries B$89.2M$471.3Mnetwork1 shared operator · same stage
Graymark Healthcare, Inc.Other Health CareSeries B$19.6M$5.9Msame sector · same stage
Frequently asked
How much funding has RT Oncology Services Corp raised?
RT Oncology Services Corp has raised approximately $56.5M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is RT Oncology Services Corp's estimated valuation?
Provath's modeled valuation for RT Oncology Services Corp is approximately $5.0M (modeled range $529K–$19.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is RT Oncology Services Corp at?
RT Oncology Services Corp's latest modeled financing stage is Series B. Its most recent recorded round closed around Fri Jul 17.
What does RT Oncology Services Corp do and where is it based?
RT Oncology Services Corp operates in the Other Health Care sector, based in SAN DIEGO.
Explore related

See where RT Oncology Services Corp sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at RT Oncology Services Corp, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.